EDITAS MEDICINE DL-,0001

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange EDITAS MEDICINE DL-,0001 stocks are traded under the ticker 8EM.

EDITAS MEDICINE DL-,0001 is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.

8EM earnings for the last quarter are −0.52 EUR per share, whereas the estimation was −0.54 EUR resulting in a 4.36% surprise. The estimated earnings for the next quarter are −0.54 EUR per share. See more details about EDITAS MEDICINE DL-,0001 earnings.

EDITAS MEDICINE DL-,0001 revenue for the last quarter amounts to ‪5.05 M‬ EUR despite the estimated figure of ‪3.50 M‬ EUR. In the next quarter revenue is expected to reach ‪3.35 M‬ EUR.

Yes, you can track EDITAS MEDICINE DL-,0001 financials in yearly and quarterly reports right on TradingView.

No, 8EM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 8EM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EDITAS MEDICINE DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.

8EM reached its all-time high on Jan 8, 2021 with the price of 76.000 EUR, and its all-time low was 4.866 EUR and was reached on Apr 26, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 28, 2024, the company has 265.00 employees. See our rating of the largest employees — is EDITAS MEDICINE DL-,0001 on this list?

We've gathered analysts' opinions on EDITAS MEDICINE DL-,0001 future price: according to them, 8EM price has a max estimate of 24.86 EUR and a min estimate of 6.45 EUR. Read a more detailed EDITAS MEDICINE DL-,0001 forecast: see what analysts think of EDITAS MEDICINE DL-,0001 and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EDITAS MEDICINE DL-,0001 EBITDA is ‪−147.78 M‬ EUR, and current EBITDA margin is −208.80%. See more stats in EDITAS MEDICINE DL-,0001 financial statements.